Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Maximising supply chain impact: 12th Global Healthcare Supply Chain Summit

On Wednesday 20 November, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will participate in a plenary session at the 2019 Global Health Supply Chain Summit in Johannesburg, South Africa. 

Date

20 November 2019

The theme of this year’s Summit is Maximizing global health supply chain impact: data and analytics, entrepreneurship and accessibility. During her presentation, Jayasree will share findings from the Foundation’s 10-year analysis of pharmaceutical companies' actions on access to medicine. Jayasree will highlight supply chain best practices and share expectations for the next decade. She will also look at the private sector’s role in supporting local manufacturing in low- and middle-income countries.

As we look ahead to 2030 and achieving the Global Goals, pharmaceutical company engagement must be sustained and expanded. The adoption of innovative practices, technologies and partnerships have the potential to help us achieve SDG 3 and reach the two billion people who currently live without access to medicine.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved